- Home
- AKRO vs CNMD Comparison
AKRO vs CNMD Comparison
Compare AKRO & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CNMD
- Stock Information
- Founded
- AKRO 2017
- CNMD 1970
- Country
- AKRO United States
- CNMD United States
- Employees
- AKRO N/A
- CNMD N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AKRO Health Care
- CNMD Health Care
- Exchange
- AKRO Nasdaq
- CNMD Nasdaq
- Market Cap
- AKRO 2.0B
- CNMD 2.1B
- IPO Year
- AKRO 2019
- CNMD 1987
- Fundamental
- Price
- AKRO $25.14
- CNMD $67.73
- Analyst Decision
- AKRO Strong Buy
- CNMD Buy
- Analyst Count
- AKRO 8
- CNMD 6
- Target Price
- AKRO $46.83
- CNMD $82.83
- AVG Volume (30 Days)
- AKRO 842.7K
- CNMD 424.2K
- Earning Date
- AKRO 02-27-2025
- CNMD 02-05-2025
- Dividend Yield
- AKRO N/A
- CNMD 1.18%
- EPS Growth
- AKRO N/A
- CNMD 127.53
- EPS
- AKRO N/A
- CNMD 4.22
- Revenue
- AKRO N/A
- CNMD $1,288,116,000.00
- Revenue This Year
- AKRO N/A
- CNMD $6.69
- Revenue Next Year
- AKRO N/A
- CNMD $7.53
- P/E Ratio
- AKRO N/A
- CNMD $16.04
- Revenue Growth
- AKRO N/A
- CNMD 10.23
- 52 Week Low
- AKRO $15.32
- CNMD $61.05
- 52 Week High
- AKRO $37.00
- CNMD $104.07
- Technical
- Relative Strength Index (RSI)
- AKRO 41.89
- CNMD 42.36
- Support Level
- AKRO $21.34
- CNMD $66.04
- Resistance Level
- AKRO $28.94
- CNMD $71.23
- Average True Range (ATR)
- AKRO 1.38
- CNMD 2.53
- MACD
- AKRO -0.27
- CNMD -0.08
- Stochastic Oscillator
- AKRO 49.67
- CNMD 35.19
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.